132Tip HCB-ONC001 ELPIS TRIAL: Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-Risk HER2-positive Breast Cancer with High HER2 Addiction and a Complete Response Following Standard Anti-Her2-based Neoadjuvant Therapy
ANNALS OF ONCOLOGY(2022)
关键词
Neoadjuvant Therapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要